The identification of CCL18 as biomarker of disease activity in localized scleroderma-Reference-Cited by-同舟云学术

The identification of CCL18 as biomarker of disease activity in localized scleroderma

Published:2019-07 Issue: Volume:101 Page:86-93
ISSN:0896-8411
Container-title:Journal of Autoimmunity
language:en
Short-container-title:Journal of Autoimmunity

Author:

Mertens J.S.,de Jong E.M.G.J.,van den Hoogen L.L.,Wienke J.,Thurlings R.M.,Seyger M.M.B.,Hoppenreijs E.P.A.H.,Wijngaarde C.A.,van Vlijmen-Willems I.M.J.J.,van den Bogaard E.,Giovannone B.,van Wijk F.,van Royen-Kerkhof A.,Marut W.,Radstake T.R.D.

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference33 articles.

1. Morphea and eosinophilic fasciitis: an update;Mertens;Am. J. Clin. Dermatol.,2017

2. Update on morphea: part I. Epidemiology, clinical presentation, and pathogenesis;Fett;J. Am. Acad. Dermatol.,2011

3. Localized scleroderma in childhood is not just a skin disease;Zulian;Arthritis Rheum.,2005

4. Clinical features of patients with morphea and the pansclerotic subtype: a cross-sectional study from the morphea in adults and children cohort;Kim;J. Rheumatol.,2014

5. Localized scleroderma is an autoimmune disorder;Takehara;Rheumatology,2005

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CCL18 promotes endometriosis by increasing endometrial cell migration and neuroangiogenesis;European Journal of Histochemistry;2024-08-06

2. Morphoea and Allied Scarring and Sclerosing Inflammatory Dermatoses;Rook's Textbook of Dermatology;2024-03-19

3. Biomarkers in skin autoimmunity—An update on localised scleroderma;Skin Health and Disease;2024-01-12

4. MIP‐4 is Induced by Bleomycin and Stimulates Cell Migration Partially via Nir‐1 Receptor;Biochemistry Research International;2024-01

5. Systemic therapy in juvenile localized scleroderma;Expert Review of Clinical Immunology;2023-07-26